GnRH antagonist (sub-therapeutic)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GnRH antagonist (sub-therapeutic), covering 2025-04-27 to 2025-04-27. Get the full timeline:
Most recent: Clinical Trial Update: Sub-therapeutic GnRH- Antagonist Treatment to Rectify LH Pulsatility in Lean Women With PCOS. [EARLY_Phase 1]